Bio-Rad Laboratories (BIO) has released an update.
Bio-Rad Laboratories, Inc. has shared an update on its investment in Sartorius AG, revealing key financial figures for the year ending December 31, 2023. Sartorius AG reported a strong financial performance with current assets of €1.96 billion, non-current assets of €7.8 billion, and a net profit of €290 million. Their sales revenue reached €3.4 billion, with a significant operating cash flow of €853.6 million. This summary is based on Sartorius AG’s consolidated financial statements and is intended for general investor awareness.
For further insights into BIO stock, check out TipRanks’ Stock Analysis page.
